Clinical Trial Update: Efficacy of Aprepitant (Emend®) in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of Aprepitant (Emend) in children for nausea and vomiting, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Cancer
• Nausea
• Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: University of Oklahoma | Conditions: Nausea, Vomiting | Phase 3 | Status: COMPLETED